Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Clinical trial NCT04299048 · COMPLETED
Trial details
- NCT number
- NCT04299048
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2022-03-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.